Log in
NYSE:HSP

808105 Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
808105 logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.38 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
CUSIP44106010
Phone+1-847-9376472
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive HSP News and Ratings via Email

Sign-up to receive the latest news and ratings for HSP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











808105 (NYSE:HSP) Frequently Asked Questions

What stocks does MarketBeat like better than 808105?

Wall Street analysts have given 808105 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 808105 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were 808105's earnings last quarter?

808105 (NYSE:HSP) issued its quarterly earnings data on Wednesday, July, 29th. The healthcare company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. The healthcare company earned $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. The firm's revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.72 earnings per share.
View 808105's earnings history
.

Who are some of 808105's key competitors?

What other stocks do shareholders of 808105 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 808105 investors own include Gilead Sciences (GILD), Johnson & Johnson (JNJ), Thermo Fisher Scientific (TMO), Twitter (TWTR), Allergan (AGN), Bank of America (BAC), Citigroup (C), Costco Wholesale (COST), Chevron (CVX) and Express Scripts (ESRX).

What is 808105's stock symbol?

808105 trades on the New York Stock Exchange (NYSE) under the ticker symbol "HSP."

What is 808105's official website?

The official website for 808105 is www.hospira.com.

How can I contact 808105?

808105's mailing address is 275 N Field Dr, LAKE FOREST, IL 60045-2579, United States. The healthcare company can be reached via phone at +1-847-9376472.

This page was last updated on 12/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.